Policy Update
Rajashree Krishna Bharadwaj
1. Background
DBT/Wellcome Trust India Alliance, known as India Alliance, is a key public charity advancing biomedical research in India through fellowships and capacity building. This policy update for IMPRI details its structure and trajectory as of early 2026, building on the prior HFSPO overview. India Alliance emerged as a £160 million equal partnership between the UK’s Wellcome Trust and India’s Department of Biotechnology (DBT) to bolster biomedical excellence. Launched around 2008, it operates as an independent public charitable trust, focusing on nurturing future science leaders amid India’s growing research ecosystem. By 2018, it had awarded over 320 fellowships across 93 institutions, with sustained growth since.
2. Functioning
It funds four fellowship tracks—Early Career, Intermediate, Senior, and a recent addition for clinicians/veterinarians—covering basic biomedical, clinical, and public health research. Applications undergo rigorous peer review by international experts to minimize conflicts, judged within career-stage peer groups for fairness. Outreach includes grants-writing workshops, public engagement, and event support to democratize access.
3. Performance
·Strengthening Biomedical Research Capacity
The India Alliance has significantly strengthened India’s biomedical, clinical, and public health research ecosystem by supporting researchers across career stages through competitive fellowship and grant programmes.
·Career Development of Researchers
Since its inception, the Alliance has funded early-career, intermediate, and senior researchers, enabling them to establish independent research careers and retain scientific talent within India.
·High-Quality and Globally Competitive Research
Research supported by the Alliance has resulted in high-impact publications, international collaborations, and contributions to global scientific knowledge in areas such as infectious diseases, non-communicable diseases, genetics, and public health.
·Institutional Reach and Inclusivity
The programme supports researchers across multiple institutions and cities in India, promoting geographic diversity and inclusion in research funding.
·Transparent and Rigorous Funding Practices
India Alliance follows robust peer-review and evaluation processes, aligned with international best practices, and is a signatory to DORA, promoting responsible research assessment.
·Governance and Financial Excellence
The Alliance has achieved Gold/Platinum certification under the Good Financial Grant Practice (GFGP) Standard, reflecting strong governance, accountability, and transparent grant management.
·Policy and Ecosystem Influence
Beyond funding, the Alliance contributes to improving research culture, funding decision frameworks, and science policy discourse in India.
·Sustained Government and International Support
Continued support from the Department of Biotechnology (Government of India) and the Wellcome Trust (UK) demonstrates confidence in the programme’s long-term impact and sustainability.
·Contribution to National Health Priorities
Research outcomes supported by the Alliance have informed health policy, clinical understanding, and innovation, aligning scientific discovery with India’s public health needs.
4. Impact
The Alliance has elevated India’s biomedical output by retaining talent, fostering high-quality international-standard research, and promoting diversity (e.g., maternity extensions). Active awards span diverse institutions, yielding leaders who enhance national health innovation and global collaborations. Its model has influenced similar initiatives, amplifying DBT’s biotechnology push.
Impact Summary Chart — DBT-Wellcome Trust/India Alliance
| Impact Indicator | Value / Statistic | Source |
| Funding committed | ~₹790Croretowards fellowships & grants | India Alliance evaluation report |
| Fellowships awarded (Phase I, first 10 yrs) | 320 awards at 93 institutions across 34 cities | DBT/Wellcome Trust 10-yr summary |
| % of awardees from India vs overseas | ~67.8%India,32.2% overseas | DBT/Wellcome Trust 10-yr summary |
| Training & human capacity | >900PhDs,postdocs& research trainees | DBT/Wellcome Trust 10-yr summary |
| Science communication training | ~2,500 researchers trained | DBT/Wellcome Trust 10-yr summary |
| Publications (2014–24) | ~194 total publications | Open COKI open access stats |
| Total citations (2014–24) | ~5.6 K citations | Open COKI open access stats |
| Open access share of publications | ~72 % | Open COKI open access stats |
| International collaboration share | ~64 % of research share in Nature Index window | Nature Index (Nov 24-Oct 25) |
| Phase III approved funding | ₹1,500 Crore (2025–31) | PolicyEdge / Cabinet approval |
| Phase III training goal | Train 2,000+ researchers & postdocs | PolicyEdge / Cabinet approval |
5. Emerging Issues
Challenges include scaling amid rising demand, navigating conflicts in India’s compact research networks via external reviews, and integrating AI/data-driven biomedicine. Gender equity persists as a focus, but broader inclusivity for non-metro institutions and post-pandemic recovery needs attention. Funding stability in volatile global philanthropy landscapes is critical.
6. Way Forward
The various ways to improve the program can be-
Prioritize expanding senior fellowships for mid-career retention, AI-biomed synergies, and pan-India outreach via virtual masterclasses.
Strengthen data-sharing mandates and alumni networks for impact tracking, while partnering with entities like HFSPO for interdisciplinary frontiers.
Advocate sustained DBT-Wellcome commitments to align with India’s 2026 biotech ambitions.
References
BioVoice News. (2018, September 24). DBT-Wellcome Trust India Alliance celebrates 10 years of enabling biomedical research in India. https://biovoicenews.com/dbt-wellcome-trust-india-alliance-celebrates-10-years-of-enabling-biomedical-research-in-india/
Curtin Open Knowledge Initiative (COKI). (n.d.). Wellcome Trust/DBT India Alliance – Open access performance. https://open.coki.ac/institution/04reqzt68/
Department of Biotechnology, Government of India. (n.d.). DBT-Wellcome Trust India Alliance. https://dbtindia.gov.in/dbtwt-india-alliance-0
Department of Biotechnology, Government of India. (n.d.). Impact analysis report: DBT-Wellcome Trust India Alliance. https://dbtindia.gov.in/sites/default/files/EOI-IMPACT-ANALYSIS-FINAL.pdf
India Alliance. (n.d.). CEO message. https://www.indiaalliance.org/CEO-message
India Alliance. (n.d.). India Alliance homepage. https://www.indiaalliance.org
India Alliance. (n.d.). Award conditions. https://www.indiaalliance.org/award-conditions
Khoj Studios. (n.d.). Wellcome Trust/DBT India Alliance. https://khojstudios.org/supporter/wellcome-trust-dbt-india-alliance/
Nature Index. (n.d.). Wellcome Trust DBT India Alliance – Institution outputs. https://www.nature.com/nature-index/institution-outputs/india/wellcome-trust-dbt-india-alliance/5a793be7b9e86be72e7842a5
OECD. (n.d.). India Alliance profile. OECD Science, Technology and Innovation Policy (STIP). https://stip.oecd.org
PolicyEdge. (2024). Cabinet approves Phase III of biomedical research partnership. https://www.policyedge.in/p/cabinet-approves-phase-iii-of-biomedical
SfDORA. (2018, August 8). Funding decisions at the Wellcome Trust–DBT India Alliance. https://sfdora.org/2018/08/08/funding-decisions-at-the-wellcome-trust-dbt-india-alliance/
Wellcome Open Research. (n.d.). About India Alliance. https://wellcomeopenresearch.org/gateways/ia/about-this-gateway
About the Contributor:
Rajashree Krishna Bharadwaj is a post graduate researcher in the field of agricultural sciences.
Acknowledgement: The author offers sincere gratitude to the IMPRI Team for sincere guidance, constructive feedback and all the support.
Disclaimer: All views expressed in the article belong solely to the author and not necessarily to the organisation.
